Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2692 participants.

Also called NCT02923726

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 2,692 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02923726
Other papers using this trial's data
  • Assessment of Antitachycardia Pacing in Primary Prevention Patients: The APPRAISE ATP Randomized Clinical Trial JAMA, 2024-11-26 DOI, PubMed 39361311, PMC11581509 PubMed links an erratum for this paper. Erratum: PMID 39960740 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Canada, Italy, Japan, South Korea, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02923726. Randomized; single masking; primary purpose basic science. Start 2016-09-30 (actual); primary completion 2023-07-06 (actual). Results posted on 2024-10-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
Acronym
APPRAISE ATP
Condition
Sudden Cardiac Death
Intervention (Device)
Arm 1 (ATP+Shock)
Intervention (Device)
Arm 2 (shock only)
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct02923726
Content hash
7196f0e0b46760633c096a8c3c77da03953abdc8a6675ce102f5ecf21c5f2f65